China Single-use Bioprocessing Market (2025-2030)
The China Single-use Bioprocessing Market was valued at $634.1 Million in 2025 and projected to reach to $1362.8 Million by 2030, representing a compound annual growth rate of 16.5%. China's single-use bioprocessing market is positioned for sustained high-growth trajectory through 2030, driven by the nation's strategic focus on biopharmaceutical self-sufficiency and technological advancement.
China Single-use Bioprocessing Market Trends and Insights
- This represents a compound annual growth rate of 16.5%, outpacing global averages and reflecting China's accelerating biopharmaceutical manufacturing capabilities.
- China's investment in advanced bioprocessing infrastructure and regulatory modernization is driving rapid adoption of single-use technologies across contract manufacturing organizations and domestic biopharmaceutical producers. The growth trajectory in China is underpinned by increasing demand for biologics, monoclonal antibodies, and cell-based therapies.
- China's pharmaceutical sector is transitioning toward higher-value manufacturing, with single-use bioprocessing systems offering flexibility, reduced contamination risk, and lower capital expenditure compared to traditional stainless-steel equipment.
- Between 2025 and 2030, China is expected to consolidate its position as a leading hub for biopharmaceutical production in Asia Pacific, supported by government incentives and growing foreign direct investment in biotech manufacturing. China's market dynamics reflect both domestic demand from expanding local biopharmaceutical companies and international outsourcing trends.
- The competitive landscape in China includes both multinational equipment suppliers and emerging local manufacturers, creating opportunities for innovation and cost optimization in single-use bioprocessing solutions..
Key Market Statistics
- CAGR (2025-2030) 16.5% CAGR
- Market Size, 2025 ~USD 634.1 Million
- Forecast, 2030 ~USD 1362.8 Million
- Country China
China Single-use Bioprocessing Market Overview
Market Valuation Growth :
China's single-use bioprocessing market is valued at $634.1 million in 2025, with projections reaching $1,362.8 million by 2030, demonstrating exceptional market expansion driven by domestic biopharmaceutical demand.
Superior Growth Rate :
China's CAGR of 16.5% significantly outpaces the global average of 13.3%, reflecting accelerated adoption of single-use technologies in Chinese bioprocessing facilities and manufacturing modernization initiatives.
Regulatory Modernization :
China's regulatory framework has evolved to support advanced bioprocessing infrastructure, enabling faster approval timelines and encouraging investment in single-use bioreactor systems and disposable technologies.
Manufacturing Capacity Expansion :
Chinese biopharmaceutical manufacturers are rapidly scaling production capabilities through single-use bioprocessing adoption, reducing capital expenditure and operational complexity while improving manufacturing flexibility.
China Single-use Bioprocessing Market Dynamics
- Government initiatives supporting domestic drug manufacturing, coupled with increasing investments from both multinational and local biotech companies, are accelerating adoption of single-use technologies across contract manufacturing organizations and integrated biopharmaceutical producers. The market expansion is further supported by China's growing pipeline of biologics, monoclonal antibodies, and cell-based therapies requiring flexible manufacturing solutions.
- Rising labor costs and environmental regulations are incentivizing the shift from traditional stainless-steel systems to cost-effective, disposable bioprocessing platforms, positioning China as a critical hub for global biopharmaceutical manufacturing..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- China's single-use bioprocessing market is projected to more than double from $634.1M (2025) to $1,362.8M (2030), growing at 16.5% CAGR.
- China's biopharmaceutical sector is rapidly adopting single-use technologies to reduce manufacturing costs and improve operational flexibility.
- Government support and regulatory modernization in China are accelerating investment in advanced bioprocessing infrastructure.
- China is emerging as a critical outsourcing destination for global biopharmaceutical manufacturers seeking cost-effective single-use bioprocessing solutions.
Single-use Bioprocessing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | CONSUMABLES (Product) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 13.3% from 2025 to 2030 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 18.03 (2025) |
| Revenue Forecast (Billions) | ~USD 33.67 (2030) |
| Segments Covered | Product, Type, Scale Range, Scale |
China Single-use Bioprocessing Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product
- Consumables
- Equipment
By Type
- 2D Bags & Containers
- 3D Bags & Containers
- Bag Assemblies
- Bottle Assemblies
- Filtration Assemblies
- Mixing System Assemblies
- Other Assemblies
- Other Single-Use Consumables
- Other Single-Use Equipment
- Single-Use Assemblies
- Single-Use Bags & Containers
- Single-Use Bioreactors
- Single-Use Chromatography Columns
- Single-Use Chromatography Systems
- Single-Use Filters
- Single-Use Filtration Systems
- Single-Use Mixing Systems
- Single-Use Sensors
By Scale Range
- 101–500 L Bioreactors
- 11–100 L Bioreactors
- 501–1,500 L Bioreactors
- >1,500 L Bioreactors
- =10 L Bioreactors
By Scale
- Manufacturing-Scale Filtration Systems
- Manufacturing-Scale Mixing Systems
- Pilot-Scale Filtration Systems
- Pilot-Scale Mixing Systems
- R&D-Scale Filtration Systems
- R&D-Scale Mixing Systems
Target Audience
- Biopharmaceutical Manufacturers : Chinese and multinational biotech companies require market intelligence to optimize single-use bioprocessing investments, evaluate manufacturing scalability, and align production strategies with market growth trajectories.
- Contract Manufacturing Organizations (CMOs) : CMOs operating in China need detailed market data to justify capital investments in single-use technologies, forecast service demand, and position competitive offerings for growing biologics manufacturing.
- Equipment & Technology Suppliers : Bioprocessing equipment manufacturers and disposable technology providers require China-specific market insights to identify customer segments, forecast demand, and develop localized product strategies.
- Private Equity & Investment Firms : Investors evaluating biotech and manufacturing opportunities in China need validated market data to assess portfolio company growth potential, sector valuations, and return on investment timelines.
- Regulatory & Consulting Professionals : Consultants advising clients on China market entry, manufacturing compliance, and technology adoption require authoritative market data to support strategic recommendations and regulatory planning.
Key Companies in the China Single-use Bioprocessing Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise valuation data for China's single-use bioprocessing market with verified CAGR of 16.5%, enabling accurate financial forecasting and investment decision-making for market entry or expansion strategies.
- Competitive Positioning Intelligence : Understand China-specific market dynamics, regulatory landscape, and manufacturing trends to benchmark competitive positioning against local and international players operating in the region.
- Investment & Expansion Planning : Leverage detailed market projections through 2030 to identify optimal timing for facility investments, technology partnerships, and capacity expansion initiatives tailored to China's accelerating biopharmaceutical sector.
- Supply Chain & Partnership Opportunities : Identify key growth segments, emerging manufacturers, and contract manufacturing organizations in China to develop strategic partnerships, distribution agreements, and supply chain collaborations.
- Regulatory & Compliance Insights : Access China-specific regulatory framework analysis and modernization trends to ensure compliant product development, manufacturing processes, and market entry strategies aligned with local requirements.
Frequently asked questions
What is the current market size of single-use bioprocessing in China?
China's single-use bioprocessing market was valued at $634.1 million in 2025 and is expected to grow to $1,362.8 million by 2030.
What is the projected growth rate for China's single-use bioprocessing market?
China's single-use bioprocessing market is projected to grow at a compound annual growth rate (CAGR) of 16.5% from 2025 to 2030.
Why is China's single-use bioprocessing market growing faster than the global average?
China's market is growing at 16.5% CAGR compared to the global rate of 13.3%, driven by rapid biopharmaceutical sector expansion, government support, and increasing adoption of cost-effective manufacturing technologies.
What are the main drivers of single-use bioprocessing adoption in China?
Key drivers include rising demand for biologics and monoclonal antibodies, lower capital expenditure requirements, reduced contamination risk, operational flexibility, and China's positioning as a global biopharmaceutical manufacturing hub.
Who are the primary end-users of single-use bioprocessing systems in China?
Primary end-users in China include contract manufacturing organizations (CMOs), domestic biopharmaceutical companies, and multinational pharmaceutical firms outsourcing production to China.
RESEARCH METHODOLOGY
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-use bioprocessing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioprocessing market. The secondary sources used for this study include the World Health Organization (WHO), the National Institutes of Health (NIH), the United States Food and Drug Administration (US FDA), the National Institute for Bioprocessing Research and Training (NIBRT), the Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), the European Patent Office (EPO), Pharmaceuticals Export Promotion Council of India (Pharmexcil), India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), the National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, BioProcess International, Journal of Bioprocessing and Biotechni ques, BioPlan Associates, Eurostat, and Factiva, research journals; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
After acquiring foundational knowledge about the global single-use bioprocessing market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs) & contract research organizations (CROs), and academic & research institutes. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.
These interviews spanned five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioprocessing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
After arriving at the overall market size from the estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioprocessing refers to the use of disposable, pre-sterilized equipment and consumables in the production of biopharmaceutical products. Single-use technologies (SUTs) include a range of products, such as bioreactors, mixers, filters, tubing, connectors, and storage bags, all designed for one-time use. Key benefits of single-use bioprocessing include reduced risk of cross-contamination, low capital and operational costs, faster turnaround times, and greater flexibility in manufacturing. These advantages make single-use systems particularly attractive to produce biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
Stakeholders
- Single-use bioprocessing equipment and consumables manufacturing companies
- Single-use bioprocessing equipment and consumables distributors
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life science companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Private research firms
Report Objectives
- To define, describe, and forecast the single-use bioprocessing market, by product, application, workflow, molecule type, and end user, in terms of value
- To forecast the size of the market segments with respect to six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
- To provide detailed information regarding the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall single-use bioprocessing market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile key players in the single-use bioprocessing market and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments in the single-use bioprocessing market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
- To benchmark players within the single-use bioprocessing market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy
Get the Full Single-use Bioprocessing Market Report
Full forecast, segment splits, and company analysis for all Single-use Bioprocessing Market.
- Canada Single-use Bioprocessing Market
- US Single-use Bioprocessing Market
- Germany Single-use Bioprocessing Market
- UK Single-use Bioprocessing Market
- France Single-use Bioprocessing Market
- Italy Single-use Bioprocessing Market
- Spain Single-use Bioprocessing Market
- South Korea Single-use Bioprocessing Market
- Japan Single-use Bioprocessing Market
- India Single-use Bioprocessing Market
- Australia Single-use Bioprocessing Market
- Brazil Single-use Bioprocessing Market
- Mexico Single-use Bioprocessing Market
- UAE Single-use Bioprocessing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report